The difunctionalization of terminal alkynes was achieved with silver fluoride (AgF) and N-bromosuccinimide (NBS) as halogen sources. The presence of the halide moiety greatly enhances the reactivity of the vinyl fluoride compounds that can probably can be transformed into various products that are difficult or even impossible to obtain via direct fluorination. Meanwhile, the monofluoro<.>alkenes were
ISOXAZOLE HYDROXAMIC ACID COMPOUNDS AS LpxC INHIBITORS
申请人:FU Jiping
公开号:US20160166548A1
公开(公告)日:2016-06-16
This invention pertains generally to compounds of Formula I as described herein and compositions containing such compounds, as well as methods of using such compounds to treat bacterial infections. In certain aspects, the invention provides methods and compositions comprising these compounds for treating infections caused by Gram-negative bacteria.